Abietic acid activates peroxisome proliferator-activated receptor-gamma (PPARgamma) in RAW264.7 macrophages and 3T3-L1 adipocytes to regulate gene expression involved in inflammation and lipid metabolism

FEBS Lett. 2003 Aug 28;550(1-3):190-4. doi: 10.1016/s0014-5793(03)00859-7.

Abstract

Abietic acid is one of the terpenoids, which are multifunctional natural compounds. It has been reported that abietic acid suppresses effects on inflammation. However, the mechanism underlying the anti-inflammatory effects remains unclear. The present work indicates that abietic acid suppresses the protein expression of tumor necrosis factor-alpha and cyclooxygenase 2, which are involved in inflammation, in lipopolysaccharide-stimulated macrophages. Moreover, this effect resembles that of thiazolidinedione, a synthetic peroxisome proliferator-activated receptor-gamma (PPARgamma) ligand. Indeed, abietic acid activates PPARgamma in luciferase reporter assays. The activity of abietic acid induces PPARgamma target gene expression in RAW264.7 macrophages and 3T3-L1 adipocytes. These data indicate that abietic acid is a PPARgamma ligand and that its anti-inflammatory effect is partly due to the activation of PPARgamma in stimulated macrophages. The present work suggests a novel possibility that abietic acid, a naturally occurring compound, can be used not only for anti-inflammation but also for regulating lipid metabolism and atherosclerosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3 Cells / drug effects
  • Abietanes*
  • Adipocytes / drug effects*
  • Adipocytes / metabolism
  • Animals
  • CD36 Antigens / drug effects
  • CD36 Antigens / genetics
  • CREB-Binding Protein
  • Cells, Cultured
  • Cyclooxygenase 2
  • Diterpenes / pharmacology*
  • Gene Expression Regulation / drug effects*
  • Inflammation / genetics
  • Isoenzymes / drug effects
  • Isoenzymes / genetics
  • Isoenzymes / metabolism
  • Ligands
  • Lipid Metabolism
  • Lipopolysaccharides / pharmacology
  • Luciferases / drug effects
  • Luciferases / genetics
  • Luciferases / metabolism
  • Macrophages, Peritoneal / drug effects*
  • Macrophages, Peritoneal / metabolism
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Nuclear Proteins / drug effects
  • Nuclear Proteins / genetics
  • Phenanthrenes / pharmacology*
  • Prostaglandin-Endoperoxide Synthases / drug effects
  • Prostaglandin-Endoperoxide Synthases / genetics
  • Prostaglandin-Endoperoxide Synthases / metabolism
  • Receptors, Cytoplasmic and Nuclear / drug effects*
  • Receptors, Cytoplasmic and Nuclear / genetics
  • Receptors, Cytoplasmic and Nuclear / metabolism
  • Thiazoles / pharmacology
  • Thiazolidinediones*
  • Trans-Activators / drug effects
  • Trans-Activators / genetics
  • Transcription Factors / drug effects*
  • Transcription Factors / genetics
  • Transcription Factors / metabolism
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Abietanes
  • CD36 Antigens
  • Diterpenes
  • Isoenzymes
  • Ligands
  • Lipopolysaccharides
  • Nuclear Proteins
  • Phenanthrenes
  • Receptors, Cytoplasmic and Nuclear
  • Thiazoles
  • Thiazolidinediones
  • Trans-Activators
  • Transcription Factors
  • Tumor Necrosis Factor-alpha
  • 2,4-thiazolidinedione
  • Luciferases
  • Cyclooxygenase 2
  • Prostaglandin-Endoperoxide Synthases
  • CREB-Binding Protein
  • Crebbp protein, mouse
  • abietic acid